Status:
RECRUITING
HoFH, the International Clinical Collaborators Registry
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
University of Amsterdam
University of Cape Town
Conditions:
Homozygous Familial Hypercholesterolemia
Eligibility:
All Genders
Brief Summary
Homozygous familial hypercholesterolemia (HoFH), a rare inherited disorder caused by bi-allelic mutations in the LDL Receptor pathway, is characterized by extremely elevated levels of low-density lipo...
Detailed Description
The HICC registry is an observational, multicenter, international registry collecting de-identified clinical and genetic information from patients with homozygous Familial Hypercholesterolemia (HoFH) ...
Eligibility Criteria
Inclusion
- Diagnosis of homozygous familial hypercholesterolemia (HoFH) clinically of genetically determined
Exclusion
- No diagnosis of HoFH
Key Trial Info
Start Date :
January 24 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04815005
Start Date
January 24 2017
End Date
December 31 2026
Last Update
December 18 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
2
Department of Vascular Medicine, Amsterdam UMC
Amsterdam, Netherlands
3
Department of Medicine, Division of Lipidology and Hatter Institute for Cardiovascular Research in Africa, University of Cape Town
Cape Town, South Africa
4
c. Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand
Johannesburg, South Africa